Joseph was diagnosed with myelofibrosis, a rare blood cancer, after returning from vacation feeling fatigued. During treatment, he learned about a clinical trial that didn’t require a risky bone marrow transplant. His health eventually improved and he became a success story for the trial. Pacritinib, later known as VONJO, received FDA approval.
Watch his full cancer vlog at the link in our bio!
#cancersurvivor #cancersurvivor #cancerstories #thepatientstory #myelofibrosis #rarecancer #MPN #cancerresearch #bloodcancer #cancertreatment #myeloproliferativeneoplasms #myeloproliferativeneoplasm #fightmyelofibrosis #raredisease #bloodcancer #hematology #diagnosis #treatment #transplant #advocacy